Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients | News & Awards - China Medical University Hospital

Other Hospital CMUH APP icon

About CMUH

News and Award

:::

News and Award/

Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

About CMUH

2025/2/17

Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

Authors : 陳柏谷(Po-Ku Chen)、陳一銘(Yi-Ming Chen)、陳建尉 (Jeremy JW Chen)、陳得源 (Der-Yuan Chen)*

Journal : Rheumatology (Oxford)

Publication Date : 2024

Link : https://pubmed.ncbi.nlm.nih.gov/39447044/

回上頁

Related Articles

Nesfatin-1 Stimulates CCL2-dependent Monocyte Migration And M1 Macrophage Polarization: Implications For Rheumatoid Arthritis Therapy img

Nesfatin-1 Stimulates CCL2-dependent Monocyte Migration And M1 Macrophage Polarization: Implications For Rheumatoid Arthritis Therapy

Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide img

Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide

Biological ageing: a promising target for prevention and management of rheumatoid arthritis. img

Biological ageing: a promising target for prevention and management of rheumatoid arthritis.

Stay connected with CMUH

youtube

How to get to CMUH the map of hospital

Download

▲

百度搜狗 360搜索搭载高阶智驾广汽本田P7将4月15日上市春日妆容【新闻特写】用生命诠释忠诚清明遇双春5人不上坟？谣言祝绪丹一分钟三种情绪变化

<code id='b4320'></code><style id='a6b16'></style>

<acronym id='d6c13'></acronym>

<center id='6eeef'><center id='56684'><tfoot id='bd5d0'></tfoot></center><abbr id='eb7c9'><dir id='00acd'><tfoot id='95098'></tfoot><noframes id='24359'>

<optgroup id='0a3a7'><strike id='5260f'><sup id='414fb'></sup></strike><code id='6cb3f'></code></optgroup>

<b id='18252'><label id='3d23b'><select id='1c59f'><dt id='14574'><span id='612bc'></span></dt></select></label></b><u id='2f9db'></u>

~~<i id='5a4a1'><strike id='3c648'><tt id='f2693'><pre id='4dcfb'></pre></tt></strike></i>~~